Top View
- Beta-Aminoisobutyric Acid As a Novel Regulator of Carbohydrate and Lipid Metabolism
- DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
- Biochemistry of Salivary Nucleotide Metabolites and Their Role in the Innate Immunity of Neonates
- Supplemental Material 1
- Effect of Redox-Cycling Agents on Nitric Oxide Synthase Activity In
- Peptide-Based Probes to Monitor Cysteine-Mediated Protein Activities
- Proteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
- MOLECULAR BASIS of FEED EFFICIENCY in MEAT-TYPE CHICKENS by JEEYOUNG LEE (Under the Direction of Dr. Samuel E. Aggrey) ABSTRACT
- Dihydropyrimidinase (DPYS) Human Shrna Lentiviral Particle (Locus ID 1807) Product Data
- A Novel Stop-Gain Mutation in DPYS Gene Causing Dihidropyrimidinase
- Identification of Potential Core Genes in Hepatoblastoma Via Bioinformatics Analysis
- Dihydropyrimidinase Deficiency: Phenotype, Genotype and Structural
- Pathway Determinants of 5-Fluorouracil Sensitivity
- Differential Gene Expression Analysis and Network Construction of Recurrent Cardiovascular Events
- Genetic Markers of 5-Fluorouracil Associated-Toxicity in Colorectal Cancer Patients by Chenjie Zeng Dissertation Submitted to Th
- Biochemical and Laboratory Aspects of Purine and Pyrimidine Metabolic Disorders
- Design and Synthesis of Novel Dihydroorotate Dehydrogenase Inhibitors by Joseph T. Madak a Dissertation Submitted in Partial
- Complement Activation in Peritoneal Dialysis–Induced Arteriolopathy
- Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
- Purine and Pyrimidine Metabolism Disorders Panel
- Blueprint Genetics DPYS Single Gene Test
- Differential P53 Signaling in Response to 5-Fu and Etoposide in Modulating
- Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells
- Generated by SRI International Pathway Tools Version 25.0 on Mon
- 23 Inborn Errors of Purine and Pyrimidine Metabolism Albert H
- Impact of DPYD, DPYS, and UPB1 Gene Variations on Severe Drug-Related Toxicity in Patients with Cancer
- Physician's Guide to the Diagnosis, Treatment, and Follow-Up Of
- Dihydropyrimidinase (DPYS) (NM 001385) Human Recombinant Protein Product Data
- Individual Genome Sequence Gene List (By Disease)
- Supplemental Data
- DPYS Gene Dihydropyrimidinase
- Metabolome Signature of Autism in the Human Prefrontal Cortex
- DPYS Antibody Cat
- Structure Function Relationships in Pyrimidine Degrading and Biocatalytic Enzymes, and Their Implications for Cancer Therapy and Green Chemistry
- NIH Public Access Author Manuscript Pharmacogenomics
- Molecular Profile of 5-Fluorouracil Pathway Genes in Colorectal Carcinoma T
- Genes by Expressed Sequence Tag Profiling Genome-Wide Analysis Of
- Altered Pre-Mrna Splicing Caused by a Novel Intronic Mutation C.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene
- DPYS (A-17): Sc-87090
- In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and -Ureidop
- Chemotherapy in Patient with Colon Cancer After Renal Transplantation a Case Report with Literature Review ∗ Wentong Fang, MD
- Electronic Supplementary Material (ESI) for RSC Advances. This Journal Is © the Royal Society of Chemistry 2017
- Generated by SRI International Pathway Tools Version 24.0 on Thu
- (12) United States Patent (10) Patent No.: US 7.426,441 B2 Mendrick Et Al